Related Experiment Videos
[Obstructive sleep apnea-related cardiovascular disease]
Richard Schulz1, Mathias Grebe, Hans-Joachim Eisele
1Medizinische Klinik II/Schlaflabor, Universitätsklinikum Giessen und Marburg, Standort Giessen, 35392 Giessen. Richard.Schulz@innere.med.uni-giessen.de
Medizinische Klinik (Munich, Germany : 1983)
|April 12, 2006
Summary
Obstructive sleep apnea (OSA) significantly increases cardiovascular disease (CVD) risk, including hypertension and heart failure. Continuous positive airway pressure (CPAP) therapy effectively mitigates these risks and improves cardiac function.
Area of Science:
- Cardiology
- Sleep Medicine
- Internal Medicine
Background:
- Obstructive sleep apnea (OSA) is strongly associated with a wide range of cardiovascular diseases (CVD), including hypertension, pulmonary hypertension, coronary artery disease, heart failure, and stroke.
- The prevalence of these conditions is substantial in OSA patients, particularly those with a high apnea-hypopnea index, and untreated OSA is linked to increased mortality.
- Cardiovascular risk in OSA is independent of confounding factors like obesity and metabolic disease, highlighting OSA as a direct contributor to CVD.
Purpose of the Study:
- To elucidate the pathophysiology of OSA-related cardiovascular disease.
- To investigate the cardioprotective effects of continuous positive airway pressure (CPAP) therapy in OSA patients.
Main Methods:
- Review of clinical spectrum and epidemiological data of OSA-related CVD.
- Elucidation of pathophysiological mechanisms including sympathetic activation, oxidative stress, inflammation, endothelial dysfunction, and atherosclerosis.
- Analysis of animal models to understand the link between OSA and hypertension.
- Evaluation of CPAP therapy's impact on vascular function, blood pressure, heart rhythm, and clinical outcomes.
Main Results:
- OSA is linked to systemic hypertension (40-60%), pulmonary hypertension (20-30%), coronary artery disease (20-30%), heart failure (5-10%), and stroke (5-10%).
- Pathophysiology involves sympathetic activation, oxidative stress, inflammation, endothelial dysfunction, and atherosclerosis.
- CPAP therapy demonstrates cardioprotective effects, including blood pressure reduction, improved endothelial function, and elimination of nocturnal arrhythmias.
- Long-term CPAP use reduces myocardial infarction and stroke rates.
Conclusions:
- OSA is a significant independent risk factor for cardiovascular disease, driven by complex pathophysiological mechanisms.
- Continuous positive airway pressure (CPAP) therapy offers substantial cardioprotective benefits, improving cardiovascular function and reducing adverse clinical events.
- Effective management of OSA through CPAP is crucial for mitigating cardiovascular morbidity and mortality.